Company Profile

Luminex Corporation is a United States-based company that is a biotechnology company. The Company is involved in developing, manufacturing and marketing biological testing technologies in the clinical diagnostic and life science industries. Its offer a solution applicable in the markets, including clinical diagnostics, pharmaceutical drug discovery, genomic and proteomic research, biomedical research and food safety.

Employees

1,325

Sector

Advanced Medical Equipment & Technology

More about the company

06-02	SMi Systems and Luminex Corporation Execute Non-Exclusive Evaluation Collaboration	CI
27/02/23	Cytek Biosciences, Inc. completed the acquisition of Flow Cytometry & Imaging business unit of Luminex Corporation for $44.9 million.	CI
13/02/23	Cytek Biosciences, Inc., Luminex Corporation - M&A Call
12/02/23	Cytek Biosciences, Inc. entered into an agreement to acquire Flow Cytometry & Imaging business unit of Luminex Corporation for $46.5 million.	CI
15/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600 Health Care	CI
15/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 1000	CI
15/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from S&P TMI Index	CI
15/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Global BMI Index	CI
15/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Composite 1500	CI
15/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600	CI
14/07/21	Luminex Corporation Announces Executive Changes	CI
14/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Composite Index	CI
13/07/21	DiaSorin S.p.A. completed the acquisition of Luminex Corporation from BlackRock, Inc., Biomedical Advanced Research And Development Authority, The Vanguard Group, Inc., RGM Capital, LLC and others.	CI

13/04/21	LUMINEX : Piper Sandler Downgrades Luminex to Neutral From Overweight; Price Target is $37	MT
13/04/21	LUMINEX : BTIG Downgrades Luminex to Neutral From Buy	MT

21/04/22	Luminex Resources Upsizes Private Placement to C$9M, Ross Beaty to Invest C$1.8 Million	AQ
15/03/22	Luminex Discovers High-grade Zone Adjacent to Los Cuyes Resource, First Hole Intercepts 8.60m at 5.39 gt AuEq	AQ
01/02/22	The Microbiome Test from Genetic Analysis AS launched on a new technology platform, GA-map® Dysbiosis Test kit now commercially available on the Luminex MAGPIX® system	AQ
27/09/21	Luminex Resources : Discovers a New Porphyry Copper Target at Cascas	AQ
29/07/21	Luminex Resources : Announces Positive Condor North Preliminary Economic Assessment, US$387 Million NPV, 12 Year Mine Life and Production of 187 Koz Gold per Year	AQ

12/04/21	Beperkte verliezen op Wall Street
12/04/21	DiaSorin S p A : Schwäbischer Kunststoff-Konzern Ritter für 890 Mio Euro verkauft
12/04/21	Dow Jones Industrial Average : Les valeurs à suivre à Wall Street
12/04/21	DiaSorin S.p.A. : le marché salue le rachat de Luminex
12/04/21	DiaSorin S p A : si rafforza negli Usa e rileva Luminex per 1,8 mld $, titolo corre

Manager	Title	Age	Since
Angelo Rago PSD	President	-	31/03/2022
Andrea Giubboni DFI	Director of Finance/CFO	-	31/08/2021
John Hoffarth TRE	Treasurer	-	13/07/2021

Luminex Corporation Share Price

Stocks

LMNX

US55027E1029

Advanced Medical Equipment & Technology

Latest news : Luminex Corporation

Analysts' recommendations: Luminex Corporation

Press Releases: Luminex Corporation

News in other languages: Luminex Corporation

Quotes and Performance

Managers and Directors: Luminex Corporation

Latest insider transactions

Other Advanced Medical Equipment & Technology

Company Profile

Director	Title	Age	Since
Loewenbaum Wally CHM	Chairman	-	30/09/2002
John Hoffarth BRD	Director/Board Member	-	13/07/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.
14/07/21	Edward A. Ogunro	Issuer sale	Director	60,893	0.1287%
14/07/21	Thomas Erickson	Issuer sale	Chief Executive Officer	187,366	0.3960%
14/07/21	Todd Bennett	Issuer sale	Responsable ventes & marketing	164,276	0.3472%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LUMINEX CORPORATION	+0.03%	+0.49%	-	-	1.74B
THERMO FISHER SCIENTIFIC, INC.	+0.14%	+2.57%	+29.28%	+2.46%	199B
DANAHER CORPORATION	+0.86%	+3.67%	+5.11%	-14.55%	142B
INTUITIVE SURGICAL, INC.	+2.47%	-2.97%	-22.10%	+12.86%	138B
BOSTON SCIENTIFIC CORPORATION	+3.22%	-0.92%	-56.80%	-15.27%	63.97B
EDWARDS LIFESCIENCES CORPORATION	-0.92%	-4.86%	+14.12%	-6.22%	50.25B
SIEMENS HEALTHINEERS AG	+1.18%	+2.27%	-23.75%	-31.73%	44.33B
AGILENT TECHNOLOGIES, INC.	-0.56%	+0.47%	+18.33%	+13.51%	38.05B
WATERS CORPORATION	-0.02%	-0.36%	+29.78%	+39.27%	36.81B
GE HEALTHCARE TECHNOLOGIES INC.	+1.53%	-0.43%	-14.62%	-20.66%	28.75B
Average	+0.76%	-0.50%	-2.30%	-2.26%	82.33B
Weighted average by Cap.	+0.97%	+0.18%	+1.22%	-1.53%